NL6406711A - - Google Patents

Info

Publication number
NL6406711A
NL6406711A NL6406711A NL6406711A NL6406711A NL 6406711 A NL6406711 A NL 6406711A NL 6406711 A NL6406711 A NL 6406711A NL 6406711 A NL6406711 A NL 6406711A NL 6406711 A NL6406711 A NL 6406711A
Authority
NL
Netherlands
Application number
NL6406711A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6406711A publication Critical patent/NL6406711A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6406711A 1963-07-10 1964-06-12 NL6406711A (en:Method)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR941004A FR1375078A (fr) 1963-07-10 1963-07-10 Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-norstéroïdes et produits en résultant
FR951379A FR1468639A (fr) 1963-07-10 1963-10-22 Nouveau stéroïde diénique 11-oxygéné et procédé de préparation
FR960726A FR5089M (en:Method) 1963-07-10 1964-01-17
FR971005A FR3845M (fr) 1963-07-10 1964-04-15 Nouveau médicament notamment pour le traitement de l'hypercholestérolémie et des troubles en résultant.

Publications (1)

Publication Number Publication Date
NL6406711A true NL6406711A (en:Method) 1965-01-11

Family

ID=27445615

Family Applications (3)

Application Number Title Priority Date Filing Date
NL121957D NL121957C (en:Method) 1963-07-10
NL6406712A NL6406712A (en:Method) 1963-07-10 1964-06-12
NL6406711A NL6406711A (en:Method) 1963-07-10 1964-06-12

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NL121957D NL121957C (en:Method) 1963-07-10
NL6406712A NL6406712A (en:Method) 1963-07-10 1964-06-12

Country Status (10)

Country Link
US (2) US3301756A (en:Method)
BE (2) BE649224A (en:Method)
BR (2) BR6459890D0 (en:Method)
CH (2) CH433276A (en:Method)
DE (2) DE1229526B (en:Method)
DK (2) DK119107B (en:Method)
FR (4) FR1375078A (en:Method)
GB (3) GB1074491A (en:Method)
NL (3) NL6406712A (en:Method)
SE (2) SE316170B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123455C (en:Method) * 1964-05-13
US3389153A (en) * 1965-08-13 1968-06-18 Merck & Co Inc 3-enol ethers of 17alpha-haloethynyl-estra 3, 5(10), 9(11)-trien-17beta-ols
FR192F (en:Method) * 1965-10-22
NL129874C (en:Method) * 1966-03-15
US3475469A (en) * 1967-06-27 1969-10-28 American Home Prod 13 - alkyl - 9 - chloromethylgon - 4-en-17beta-ol-3-ones and intermediates therefor
WO2007002737A2 (en) * 2005-06-28 2007-01-04 E. I. Du Pont De Nemours And Company High work function transparent conductors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211764A (en) * 1963-09-25 1965-10-12 American Cyanamid Co 19-norandrostadienes and method of preparing the same

Also Published As

Publication number Publication date
DE1232577B (de) 1967-01-19
DK112796B (da) 1969-01-20
CH433276A (fr) 1967-04-15
BR6459890D0 (pt) 1973-08-09
BE649223A (en:Method)
GB1074495A (en) 1967-07-05
US3282785A (en) 1966-11-01
GB1074491A (en) 1967-07-05
DK119107B (da) 1970-11-16
DE1229526B (de) 1966-12-01
CH432504A (fr) 1967-03-31
FR1468639A (fr) 1967-02-10
NL6406712A (en:Method) 1965-01-11
BE649224A (en:Method)
FR3845M (fr) 1966-01-17
BR6459891D0 (pt) 1973-09-11
SE316170B (en:Method) 1969-10-20
SE316172B (en:Method) 1969-10-20
GB1074492A (en) 1967-07-05
NL121957C (en:Method)
FR5089M (en:Method) 1967-05-22
FR1375078A (fr) 1964-10-16
US3301756A (en) 1967-01-31

Similar Documents

Publication Publication Date Title
FR5089M (en:Method)
BE645136A (en:Method)
BE631702A (en:Method)
BE626867A (en:Method)
BE626826A (en:Method)
BE626803A (en:Method)
BE626590A (en:Method)
BE626358A (en:Method)
BE625880A (en:Method)
BE625828A (en:Method)
BE625825A (en:Method)
BE625136A (en:Method)
BE623220A (en:Method)
BE627145A (en:Method)
BE624982A (en:Method)
BE645531A (en:Method)
BE645413A (en:Method)
BE623117A (en:Method)
BE645245A (en:Method)
BE645226A (en:Method)
BE644379A (en:Method)
BE626915A (en:Method)
BE623490A (en:Method)
BE624811A (en:Method)
BE623162A (en:Method)